ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
RapidPulse secured $48 million in Series B funding. The round supports the company's development of its pulsed field ablation system for treating atrial fibrillation. The funding will accelerate clinical trials and commercial expansion of the medical device technology.
Tap to vote and see what everyone thinks.
Summary by ByteBrief